Hims & Hers Stock Plunges While Novo Nordisk Gains as Weight-Loss Drug Wars Take New TurnInvestopedia • 02/09/26
Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injectionsCNBC • 02/09/26
Novo Nordisk Plunges Nearly 15% After Earnings. Here's What Investors Need to Know.The Motley Fool • 02/08/26
Heard on the Street: : The obesity-market price war has turned traditional pharma economics upside down.WSJ • 02/07/26
Citi flags lingering risks to Novo despite strong weight-loss portfolioProactive Investors • 02/06/26
Novo Stock Rises, Hims & Hers Tanks. This Could Shift the Weight-Loss Copycat Battle.Barrons • 02/06/26
Novo Nordisk stock climbs out of hole on FDA chief's threat to block Hims and Hers pillMarket Watch • 02/06/26